A. M. Castle & Co. Reports Second Quarter 2016 Results
Aug 09, 2016 12:00 pm UTC| Business
OAK BROOK, Ill., Aug. 09, 2016 -- A. M. Castle Co. (NYSE:CAS) (the “Company” or “Castle”),a global distributor of specialty metal and supply chain solutions, today reported financial results for the second quarter...
Micron Introduces Mobile 3D NAND Solution for Next-Generation Smartphones
Aug 09, 2016 12:00 pm UTC| Business
SANTA CLARA, Calif., Aug. 09, 2016 -- Micron Technology, Inc., (Nasdaq:MU) today introduced the company’s first 3D NAND memory technology optimized for mobile devices and its first products based on the Universal Flash...
Interleukin Genetics Announces Conference Call to Discuss Second Quarter 2016 Financial Results
Aug 09, 2016 12:00 pm UTC| Business
WALTHAM, Mass., Aug. 09, 2016 -- Interleukin Genetics, Inc. (OTCQB:ILIU) announced today that it will host a conference call and webcast on Tuesday, August 16, 2016, at 8:30 a.m. Eastern Time to provide a corporate...
Lipocine Announces Financial and Operational Results for the Second Quarter of 2016
Aug 09, 2016 12:00 pm UTC| Business
SALT LAKE CITY, Aug. 09, 2016 -- Lipocine Inc. (NASDAQ:LPCN), a specialty pharmaceutical company, today announced financial and operational results for the quarter ended June 30, 2016. Quarterly and Recent Highlights ...
ADDvantage Technologies Announces Financial Results for the Fiscal Third Quarter of 2016
Aug 09, 2016 12:00 pm UTC| Business
BROKEN ARROW, Okla., Aug. 09, 2016 -- ADDvantage Technologies Group, Inc. (NASDAQ:AEY), today announced its financial results for the three and nine month periods ended June 30, 2016. “Our results for the third fiscal...
Aptose Biosciences to Present at Canaccord Genuity 36th Annual Growth Conference
Aug 09, 2016 12:00 pm UTC| Business
SAN DIEGO and TORONTO, Aug. 09, 2016 -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer,...
Galectin Therapeutics Reports Second Quarter 2016 Financial Results and Provides Business Update
Aug 09, 2016 12:00 pm UTC| Business
Top-line data from NASH-FX trial in NASH patients with advanced fibrosis expected to be reported by the end of September Australian patent allowance strengthens global intellectual property franchise NORCROSS, Ga., Aug....